AMERICAN VANGUARD CORP
AVDNYSE
$2.61
↓ -3.0%Jul 17 close · end-of-day
Price
1Y↓ -28.3%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$74.8M
Enterprise Value
$341.4M
P/E
—
P/S
0.1
P/B
0.4
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$522.9M
Net Income (TTM)
-$45.6M
Free Cash Flow (TTM)
—
Gross Margin
29.8%
Operating Margin
-4.2%
Net Margin
-8.7%
ROE
-24.0%
ROIC
-3.8%
Debt / Equity
1.4
Net Cash
-$266.6M
Return 1Y
-26.7%
Company profile
American Vanguard Corporation develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, soil health, plant nutrition, growth regulators, and soil fumigants. The company was incorporated in 1969 and is headquartered in Newport Beach, California.
- CEO
- Eric G. Wintemute
- Sector
- Manufacturing
- Industry
- Chemicals
- Employees
- 800
- Headquarters
- California
- Website
- american-vanguard.com
Management & directors
- Kaye DouglasCHIEF EXECUTIVE OFFICER
- Eilers PeterSee Remarks
Roles derived from SEC Form 4 filings.
Earnings
AVD Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$123.6M↑ +6.7%
Diluted EPS-$0.14↓ -53.3%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $458.7M | $557.7M | $609.6M | $579.4M | $547.3M | $515.1M |
| Gross profit | $172.6M | $170.7M | $192.4M | $179.2M | $120.3M | $147.6M |
| Operating income | $22.9M | $30.9M | $40.7M | $23.3M | -$101.6M | -$28.3M |
| Net income | $15.2M | $18.6M | $27.4M | $7.5M | -$124.9M | -$49.9M |
| Diluted EPS | $0.51 | $0.61 | $0.92 | $0.26 | -$4.50 | -$1.75 |
| Operating cash flow | $90.3M | $86.4M | $57.1M | -$58.7M | $3.9M | -$21.2M |
| Free cash flow | — | — | — | — | — | — |
| Gross margin | 37.6% | 30.6% | 31.6% | 30.9% | 22.0% | 28.6% |
| Operating margin | 5.0% | 5.5% | 6.7% | 4.0% | -18.6% | -5.5% |
| Net margin | 3.3% | 3.3% | 4.5% | 1.3% | -22.8% | -9.7% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $128.2M | $118.3M | $165.6M | $115.8M | $129.3M | $119.3M | $150.7M | $123.6M |
| Gross profit | $37.8M | $17.3M | $22.8M | $30.2M | $40.5M | $34.2M | $42.6M | $38.4M |
| Operating income | -$9.2M | -$28.4M | -$70.0M | -$4.3M | $4.4M | -$6.5M | -$21.8M | $1.9M |
| Net income | -$11.7M | -$25.7M | -$88.9M | -$8.5M | -$849,000.00 | -$12.4M | -$28.2M | -$4.1M |
| Diluted EPS | -$0.42 | -$0.91 | -$3.23 | -$0.30 | -$0.03 | -$0.43 | -$0.99 | -$0.14 |
| Operating cash flow | -$13.3M | $27.9M | $25.4M | -$20.6M | -$19.3M | $12.7M | $6.0M | -$35.4M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | 29.5% | 14.6% | 13.8% | 26.1% | 31.4% | 28.7% | 28.3% | 31.1% |
| Operating margin | -7.2% | -24.0% | -42.3% | -3.7% | 3.4% | -5.5% | -14.5% | 1.5% |
| Net margin | -9.1% | -21.8% | -53.7% | -7.3% | -0.7% | -10.4% | -18.7% | -3.4% |
Company news
May 30, 2026
May 7, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-10 | Kaye Douglas· CHIEF EXECUTIVE OFFICER | J | 6,527 | $2.36 | $15,403.72 | filing |
| 2026-06-04 | ROSENBLOOM KEITH M | Award | 31,872 | $0.00 | $0.00 | filing |
| 2026-06-04 | McDougal Rubin J | Award | 31,872 | $0.00 | $0.00 | filing |
| 2026-06-04 | Gottschalk Patrick E | Award | 31,872 | $0.00 | $0.00 | filing |
| 2026-06-04 | Macicek Steven D | Award | 31,872 | $0.00 | $0.00 | filing |
| 2026-06-04 | Bassett Mark R | Award | 31,872 | $0.00 | $0.00 | filing |
| 2026-06-04 | Angelini Marisol | Award | 31,872 | $0.00 | $0.00 | filing |
| 2026-06-03 | Kaye Douglas· CHIEF EXECUTIVE OFFICER | Buy | 5,000 | $2.50 | $12,500.00 | filing |
| 2026-05-19 | Gottschalk Patrick E | Buy | 25,000 | $2.70 | $67,500.00 | filing |
| 2026-05-13 | Gottschalk Patrick E | Buy | 20,000 | $2.95 | $59,000.00 | filing |
| 2026-05-12 | Gottschalk Patrick E | Buy | 20,000 | $2.92 | $58,400.00 | filing |
| 2026-01-29 | Kaye Douglas· CHIEF EXECUTIVE OFFICER | I | 4,790 | $3.26 | $15,615.40 | filing |
| 2025-11-26 | Gottschalk Patrick E | J | 47,281 | $0.00 | $0.00 | filing |
| 2025-11-26 | ROSENBLOOM KEITH M | J | 217,503 | $0.00 | $0.00 | filing |
| 2025-11-26 | Bassett Mark R | J | 23,636 | $0.00 | $0.00 | filing |
| 2025-09-04 | Eilers Peter· See Remarks | Sale | 6,000 | $5.35 | $32,100.00 | filing |
| 2025-08-07 | ROSENBLOOM KEITH M | Award | 17,621 | $0.00 | $0.00 | filing |
| 2025-08-07 | Bassett Mark R | Award | 17,621 | $0.00 | $0.00 | filing |
| 2025-08-07 | Tiu de Mino Carmen | Award | 17,621 | $0.00 | $0.00 | filing |
| 2025-08-07 | Angelini Marisol | Award | 17,621 | $0.00 | $0.00 | filing |
| 2025-08-07 | Gunter Emer | Award | 8,810 | $0.00 | $0.00 | filing |
| 2025-08-07 | Macicek Steven D | Award | 17,621 | $0.00 | $0.00 | filing |
| 2025-08-07 | Baskin Scott | Award | 8,810 | $0.00 | $0.00 | filing |
| 2025-08-07 | Gottschalk Patrick E | Award | 17,621 | $0.00 | $0.00 | filing |
Latest 24 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.